QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call Transcript

SA Transcripts158.32K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call February 11, 2026 5:00 PM EST Company Participants Juliet Cunningham - Vice President of Investor RelationsBrian Blaser - President, CEO & DirectorJonathan Siegrist - Executive VP of Research & Development and CTOJoseph Busky - Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies LLC, Research DivisionJack Meehan - Nephron Research LLCAndrew Brackmann - William Blair & Company L.L.C., Research DivisionPatrick Donnelly - Citigroup Inc., Research DivisionLu Li - UBS Investment Bank, Research DivisionAndrew Cooper - Raymond James & Associates, Inc., Research DivisionCasey Woodring - JPMorgan Chase & Co, Research DivisionWilliam Bonello - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Good morning or good afternoon. Welcome to the QuidelOrtho Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast. [Operator Instructions] Please note this conference call is being recorded. An audio replay of the conference call will be available on the company's website shortly after this call. I would now like to turn the call over to Juliet Cunningham, Vice President of Investor Relations. Thank you. Juliet CunninghamVice President of Investor Relations Thank you. Good afternoon, everyone. Thanks for joining us. With me today are Brian Blaser, President and Chief Executive Officer; Jonathan Siegrist, Chief Technology Officer; and Joe Busky, Chief Financial Officer. This conference call is being simultaneously webcast on the Investor Relations page of our website. To assist in the presentation, we also posted supplemental information on our IR page that will be referenced throughout this call. This conference call and supplemental information contains forward-looking statements, which are made as of today, February 11, 2026. We assume no obligation to update any forward-looking statement, except as required by law. Statements that are not strictly historical, including the company's expectations, plans, financial guidance, future performance and prospects are forward-looking statements